About Tirzepatide
Tirzepatide is a medication that acts on hormone pathways involved in appetite and metabolism. Certain FDA-approved tirzepatide products have been studied in clinical trials for type 2 diabetes and weight management.
These clinical studies apply only to FDA-approved medications. Compounded formulations, including sublingual versions, have not been evaluated by the FDA for safety or efficacy.
Compounded Sublingual Tirzepatide
Compounded sublingual tirzepatide is prepared by licensed compounding pharmacies when prescribed by a healthcare provider. These formulations are not FDA-approved and may differ from FDA-approved tirzepatide products in formulation, dosing, absorption, and available supporting evidence.
Your healthcare provider will determine whether a compounded formulation is appropriate for your individual health needs.
Possible Experiences and Considerations
People may have different experiences when using tirzepatide-based treatments. Some individuals report digestive symptoms such as nausea, vomiting, or stomach discomfort. Others may not notice these changes. Experiences vary widely from person to person.
If you experience symptoms that concern you or have questions about how you are feeling while using your medication, contact your healthcare provider. They can review your situation and determine what steps may be appropriate.
Tirzepatide should only be taken under the supervision of a licensed healthcare professional.

Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under medical supervision and may differ in formulation, dosing, and supporting evidence from FDA-approved products.

This article is for general informational purposes only and does not provide medical advice, diagnosis or treatment for any specific person.